PLFLF.US PlantFuel Life Inc
- Market cap
- USD 1.80K
- P/E
- -
- P/B
- 0.38x
- ROE
- -381.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2023.
Is PLFLF.US undervalued?
Graham numberThe Graham number of PlantFuel Life Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
PlantFuel Life Inc fundamental analysis
No fundamental analysis for PlantFuel Life Inc yet.
PlantFuel Life Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About PlantFuel Life Inc
PlantFuel Life Inc., a plant-based wellness company, provides health supplements, nutraceuticals, and plant protein-based products under the PlantFuel brand name in the United States. The company was formerly known as Sire Bioscience Inc. and changed its name to PlantFuel Life Inc. in April 2021. PlantFuel Life Inc. is headquartered in Mississauga, Canada.
Full company profilePlantFuel Life Inc financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 3 quarters up to Jun 30, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
PlantFuel Life Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | - | 1.80K | 116.00 | 50.0K | 125K | 0.00 | 492K | 1.05M | 907K | 77.8K |
| Gross Profit | - | - | 1.80K | 116.00 | 50.0K | - | 0.00 | 94.5K | 24.3K | -9.82K | -6.35K |
| Operating Income | -15.5K | -791K | -338K | -143K | -370K | -1.76M | -1.56M | -1.35M | -13.3M | -37.7M | -2.54M |
| EBITDA | -15.5K | -332K | -338K | -143K | -370K | - | -1.56M | -1.30M | -9.90M | -31.5M | -2.51M |
| Net Income | -15.4K | -789K | -336K | -142K | -276K | -1.88M | -6.40M | -2.07M | -13.4M | -37.9M | -2.57M |
| EPS | -0.67 | -17 | -6.91 | -2.80 | -3.73 | -0.16 | -27 | -3.02 | -7.08 | -11 | -0.28 |
| Balance Sheet | |||||||||||
| Total Assets | 293K | 166K | 200K | 70.6K | 931K | 534K | 7.64M | 7.18M | 31.2M | 4.15M | 8.11M |
| Total Liabilities | 2.50K | 24.2K | 25.7K | 22.6K | 81.2K | 261K | 5.02M | 6.45M | 1.56M | 7.14M | 7.43M |
| Shareholders' Equity | 291K | 142K | 174K | 48.0K | 850K | 273K | 2.62M | 734K | 29.7M | -2.99M | 673K |
| Cash & Short-term Investments | 263K | 160K | 198K | 69.7K | 499K | 372K | 1.66M | 77.3K | 297K | 5.27K | 61.9K |
| Total Debt | - | - | - | - | - | - | 4.84M | 5.44M | 28.9K | 2.75M | 3.34M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -12.9K | -285K | -323K | -173K | -320K | 18.5K | -581K | -1.07M | -7.21M | -4.86M | -1.92M |
| Capital Expenditure | 30.0K | 0.00 | 0.00 | 0.00 | 0.00 | 9.92M | 62.2K | 397K | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -42.9K | -285K | -323K | -173K | -320K | -1.29M | -643K | -1.46M | -7.21M | -4.86M | -1.92M |
| Ratios | |||||||||||
| ROE | -5.3% | -556.6% | -192.8% | -295.3% | -32.5% | -690.6% | -244.5% | -282.6% | -45.1% | - | -381.6% |
| ROA | -5.3% | -475.5% | -168.1% | -200.6% | -29.7% | -352.8% | -83.7% | -28.9% | -42.9% | -914.8% | -31.7% |
| Net Profit Margin | - | - | -18,665.2% | -122,172.4% | -552.4% | -1,507.2% | - | -421.3% | -1,272.0% | -4,180.8% | -3,303.1% |
| Debt to Equity | - | - | - | - | - | - | 1.85x | 7.41x | 0.00x | - | 4.97x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
PlantFuel Life Inc dividends
PlantFuel Life Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:10 on Jun 6, 2023.
Who owns PlantFuel Life Inc
- Insiders 3.22%
- Institutions 0.00%
- Public & others 96.78%
- Shares outstanding 18.0M
- Free float 18.0M
PlantFuel Life Inc company profile
- Company name
- PlantFuel Life Inc
- Ticker
- PLFLF.US
- ISIN
- CA72748Q1164
- Exchange
- USA Stocks
- Sector
- Consumer Defensive
- Industry
- Food Products
- Fiscal year end
- September
- Address
- 2500 Meadowpine Blvd., Mississauga, ON, Canada, L5N 6C4
- Phone
- 877 312 8900
- Website
- plantfuel.com
About PlantFuel Life Inc
PlantFuel Life Inc., a plant-based wellness company, provides health supplements, nutraceuticals, and plant protein-based products under the PlantFuel brand name in the United States. The company was formerly known as Sire Bioscience Inc. and changed its name to PlantFuel Life Inc. in April 2021. PlantFuel Life Inc. is headquartered in Mississauga, Canada.
PlantFuel Life Inc management
4- Ms. Maria DanePresident
- Mr. Tony QianCEO & Interim CFO
- Mr. Jeffrey ZaniniStrategic Advisor · born 1968
- Dr. Anthony Galea M.D.Chief Medical Officer